Efficacy, safety of hydroxychloroquine vs placebo to prevent SARS-CoV-2 infection among health care


What The Study Did: In this randomized clinical trial, daily hydroxychloroquine didn’t prevent SARS-CoV-2 infection among hospital-based health care workers, although the trial was terminated early.

Authors: Ravi K. Amaravadi, M.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/


Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.


Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.6319?guestAccessKey=053387bf-8cfb-4ea9-952c-1dd260fd4aed&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=093020

Media Contact
JAMA Network Media Relations

[email protected]

Leave A Reply

Your email address will not be published.